Outpatient subcutaneous interleukin-2 and interferon-alpha for metastatic renal cell cancer: five-year follow-up of the Cytokine Working Group Study.

Source:http://linkedlifedata.com/resource/pubmed/id/9161781

Download in:

View as

General Info

PMID
9161781